(NASDAQ: CDIO) Cardio Diagnostics Holdings's forecast annual revenue growth rate of 2,539.97% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Cardio Diagnostics Holdings's revenue in 2024 is $17,065.On average, 1 Wall Street analysts forecast CDIO's revenue for 2024 to be $14,681,961, with the lowest CDIO revenue forecast at $14,681,961, and the highest CDIO revenue forecast at $14,681,961. On average, 1 Wall Street analysts forecast CDIO's revenue for 2025 to be $215,911,190, with the lowest CDIO revenue forecast at $215,911,190, and the highest CDIO revenue forecast at $215,911,190.
In 2026, CDIO is forecast to generate $539,777,975 in revenue, with the lowest revenue forecast at $539,777,975 and the highest revenue forecast at $539,777,975.